# FDA 483 - UCB Pharma SA, Braine - April 21, 2023

Source: https://www.globalkeysolutions.net/records/483/ucb-pharma-sa-braine/72fa4839-b474-44ed-ad14-cebb7e7da18e

> FDA 483 for UCB Pharma SA, Braine on April 21, 2023. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: UCB Pharma SA, Braine
- Inspection Date: 2023-04-21
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Officers

- [Consumer Safety Officer at FDA](https://www.globalkeysolutions.net/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)
- [Harnet M. Toure](https://www.globalkeysolutions.net/people/harnet-m-toure/bb072cd0-7006-4054-8d1a-d26cccb97862)
- [Madhusini Dharmasena](https://www.globalkeysolutions.net/people/madhusini-dharmasena/f78bfd9f-9611-435e-a21c-3db2d51f0f5b)

Company: https://www.globalkeysolutions.net/companies/ucb-pharma-sa-braine/b676805f-c88b-44c4-86ef-dbe9ef2419d6

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c